Literature DB >> 32056520

Talin: A Potential Drug Target for Cancer Therapy.

Rama Rao Malla1, Rahul Kumar Vempati1.   

Abstract

Talin is an intracellular cytoskeletal protein and one of the major components of the focal adhesion complex. It mainly acts as an interlink between transmembrane integrin receptors and cytosolic F-actin. Apart from integrins and actin, it also interacts with various other proteins in the adhesion complex to regulate their functional dynamics. Talin undergoes a variety of post-translational modifications and they are implicated in the control of cell motility. There are two talin isoforms (talin1 and talin2) in mammals and they are encoded by TLN1 and TLN2 genes, respectively. Recent studies showed that both the isoforms have some mechanistic dissimilarities in terms of their interaction with membrane-bound integrins. Among the two isoforms, talin1 was well studied, and most of the information available till now comes from talin1. The present review is aimed to provide an updated overview on the cellular significance of talin in normal and cancerous cells. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; extra cellular matrix; focal adhesions; knock out; post translational modifications; talin.

Mesh:

Substances:

Year:  2020        PMID: 32056520     DOI: 10.2174/1389200221666200214114018

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  8 in total

1.  [Talin1 is highly expressed in the fallopian tube and chorionic villi to promote trophoblast invasion in tubal pregnancy].

Authors:  P Qiu; X Lin; G Deng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-04-20

2.  Global Proteomics Analysis of Bone Marrow: Establishing Talin-1 and Centrosomal Protein of 55 kDa as Potential Molecular Signatures for Myelodysplastic Syndromes.

Authors:  Arlindo A Moura; Maria Julia B Bezerra; Aline M A Martins; Daniela P Borges; Roberta T G Oliveira; Raphaela M Oliveira; Kaio M Farias; Arabela G Viana; Guilherme G C Carvalho; Carlos R K Paier; Marcelo V Sousa; Wagner Fontes; Carlos A O Ricart; Maria Elisabete A Moraes; Silvia M M Magalhães; Cristiana L M Furtado; Manoel O Moraes-Filho; Claudia Pessoa; Ronald F Pinheiro
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

3.  Talin1 Induces Epithelial-Mesenchymal Transition to Facilitate Endometrial Cell Migration and Invasion in Adenomyosis Under the Regulation of microRNA-145-5p.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Sci       Date:  2021-02-04       Impact factor: 3.060

4.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

5.  Formation of Aberrant Myotubes by Myoblasts Lacking Myosin VI Is Associated with Alterations in the Cytoskeleton Organization, Myoblast Adhesion and Fusion.

Authors:  Lilya Lehka; Małgorzata Topolewska; Dominika Wojton; Olena Karatsai; Paloma Alvarez-Suarez; Paweł Pomorski; Maria Jolanta Rędowicz
Journal:  Cells       Date:  2020-07-11       Impact factor: 6.600

6.  Cancer associated talin point mutations disorganise cell adhesion and migration.

Authors:  Latifeh Azizi; Alana R Cowell; Vasyl V Mykuliak; Benjamin T Goult; Paula Turkki; Vesa P Hytönen
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

7.  UbiComb: A Hybrid Deep Learning Model for Predicting Plant-Specific Protein Ubiquitylation Sites.

Authors:  Arslan Siraj; Dae Yeong Lim; Hilal Tayara; Kil To Chong
Journal:  Genes (Basel)       Date:  2021-05-11       Impact factor: 4.096

8.  CircRNA_400029 promotes the aggressive behaviors of cervical cancer by regulation of miR-1285-3p/TLN1 axis.

Authors:  Yue Ma; Jing Liu; Zhuo Yang; Peng Chen; Dan-Bo Wang
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.